The Bottom Line: Hepatitis B serologic testing involves measurement of several hepatitis B virus (HBV)-specific antigens and antibodies. Different serologic “markers” or combinations of markers are used to identify different phases of HBV infection and to determine whether a patient has acute or chronic HBV infection, is immune to HBV as a result of prior infection or vaccination, or is susceptible to infection (CDC, 2016).
References: CDC. (2016). Interpretation of Hepatitis B serologic test results [Table]. Hepatitis B FAQs for Health Professionals. Retrieved from https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#general
CDC. (2008). Acute Hepatitis B Virus infection with recovery [Chart]. California Department of Public Health: Hepatitis B. Retrieved from https://www.cdph.ca.gov/HealthInfo/discond/Pages/HepatitisB.aspx